Marilyn Yager
🏛️ Revolving DoorFormer Government Position:
Deputy Assistant to the President, White House Office of Public Liaison.
🤖
AI Overview
Marilyn Yager has appeared in 816 federal lobbying filings at Alston & Bird LLP, representing 40 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 16 policy areas.
816
Total Filings
1
Firms
40
Clients
16
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 106 | 18 |
| 2019 | 96 | 17 |
| 2020 | 97 | 18 |
| 2021 | 84 | 15 |
| 2022 | 83 | 14 |
| 2023 | 143 | 21 |
| 2024 | 115 | 19 |
| 2025 | 92 | 16 |
Firms
Alston & Bird LLP816 filings
Top Clients
Travere Therapeutics93 filings
Hologic, INC.55 filings
The Metrohealth System52 filings
Colorado Hospital Association49 filings
Novo Nordisk INC.36 filings
Dana-farber Cancer Institute, INC.35 filings
Regents of the University of Michigan30 filings
The Nrp Group LLC30 filings
Tennessee Hospital Association30 filings
Massachusetts Hospital Association28 filings
St. Jude Children's Research Hospital24 filings
Hospital Association of Oregon22 filings
Premier, INC.21 filings
Washington State Hospital Association20 filings
Regional One Health16 filings
National Brain Tumor Society16 filings
American Ambulance Association15 filings
Boston Scientific Corporation15 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.